U.S. Physical Therapy, Inc. (USPH) Revenue History
U.S. Physical Therapy, Inc. (USPH) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $356.55M |
| 2017-12-31 | $414.05M |
| 2018-12-31 | $453.91M |
| 2019-12-31 | $481.97M |
| 2020-12-31 | $422.97M |
| 2021-12-31 | $495.02M |
| 2022-12-31 | $553.14M |
| 2023-12-31 | $604.80M |
| 2024-12-31 | $671.35M |
| 2025-12-31 | $780.99M |
How USPH compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| VREX | Varex Imaging Corporation | $844.60M |
| MYGN | Myriad Genetics Inc. | $824.50M |
| EBS | Emergent BioSolutions Inc. | $742.90M |
| NEO | NeoGenomics Inc. | $727.33M |
| AMPH | Amphastar Pharmaceuticals Inc. | $719.89M |
These are five companies in the same sector as USPH with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get U.S. Physical Therapy, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("USPH", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | USPH | $78.21 | +0.86% | 0.17M |
| 3 | ||||
| 4 | ||||
| 5 |